


Searching News Database: cellular therapy
HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
HSMN NewsFeed - 5 Jan 2021
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
HSMN NewsFeed - 16 Jun 2020
EXUMA Biotech Adds H. Michael Shepard to Scientific Advisory Board and Steven R. Frank to Board of Directors
EXUMA Biotech Adds H. Michael Shepard to Scientific Advisory Board and Steven R. Frank to Board of Directors
HSMN NewsFeed - 13 Jun 2019
Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering
Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering
HSMN NewsFeed - 25 Jan 2019
Medical-Fish-Skin Company Kerecis Hires Stephen DiBiasio as Executive Vice President
Medical-Fish-Skin Company Kerecis Hires Stephen DiBiasio as Executive Vice President
HSMN NewsFeed - 29 Nov 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
HSMN NewsFeed - 7 Aug 2017
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
HSMN NewsFeed - 28 Apr 2017
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 1 Oct 2014
Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline
Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline
HSMN NewsFeed - 16 Jun 2014
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
HSMN NewsFeed - 14 Mar 2012
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory Affairs
HSMN NewsFeed - 7 Mar 2011
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
HSMN NewsFeed - 9 Mar 2010
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
HSMN NewsFeed - 1 Feb 2010
Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
HSMN NewsFeed - 11 Feb 2009
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
HSMN NewsFeed - 15 Jul 2008
Neoprobe Signs Non-Binding Letter of Intent for Lymphoseek European Distribution
Neoprobe Signs Non-Binding Letter of Intent for Lymphoseek European Distribution
HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
HSMN NewsFeed - 20 Dec 2007
Neoprobe Announces Extension of Marketing Agreement with Ethicon Endo-Surgery, Inc.
Neoprobe Announces Extension of Marketing Agreement with Ethicon Endo-Surgery, Inc.
HSMN NewsFeed - 7 Nov 2007
Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial
Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial
HSMN NewsFeed - 11 Sep 2007
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
HSMN NewsFeed - 11 Jul 2007
StemCyte Appoints Robert Dickey IV as Senior Vice President and Chief Financial Officer
StemCyte Appoints Robert Dickey IV as Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 31 May 2006
ThermoGenesis & NETCORD Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims
ThermoGenesis & NETCORD Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims
Additional items found! 31
Members Archive contains
31 additional stories matching:
cellular therapy
(Password required)
cellular therapy
(Password required)
